Yabao Pharmaceuticals And Salus Pharma LLC Announce Strategic Partnership For Generic Drugs

BEIJING & MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Yabao Pharmaceutical Co, Inc. (Shanghai Stock Exchange 600351) and Salus Pharma LLC today announced a strategic partnership to co-develop, manufacture and commercialize high technological barrier generic drugs worldwide.

“Yabao is excited to collaborate with Salus Pharma, a specialty pharmaceutical company engaged in the research and development of high technological barrier controlled release formulation. This transaction represents our first generic drug partnership with Salus within this year”

Under the terms of the agreement, Yabao will exclusively own rights to commercialize certain Salus Pharma-developed products outside the U.S. and to manufacture for worldwide markets, while Salus Pharma will retain rights to commercialize in the U.S. Financial terms were not disclosed.

“Yabao is excited to collaborate with Salus Pharma, a specialty pharmaceutical company engaged in the research and development of high technological barrier controlled release formulation. This transaction represents our first generic drug partnership with Salus within this year,” commented Dr. Peng Wang, President of R&D and Head of International Business, Yabao Pharmaceutical Co. “This partnership further demonstrates that Yabao’s competitive R&D and manufacturing have expanded into developed markets.”

About Yabao Pharmaceutical Co.

Yabao Pharmaceutical Co. (Shanghai Stock Exchange 600351) is a leading China pharmaceutical company with fully integrated development, manufacturing, and commercialization capabilities. Yabao recently has been pursuing strategic development and commercialization partnerships to bring high quality innovative or generic medicines into China. In addition to strong clinical and regulatory capabilities, Yabao has extensive expertise in formulation and API production and meets current Good Manufacturing Practice (cGMP) requirements with two manufacturing sites approved by U.S. FDA and a European agency, respectively. For more information about Yabao Pharmaceutical Co., please visit www.yabao.com.cn.

About Salus Pharma LLC

Salus Pharma LLC (Monmouth Junction, New Jersey) is a privately held, technology driven specialty pharmaceutical company engaged in drug delivery technology development and generic & innovative product development & manufacturing. Salus Pharma LLC utilizes its established drug delivery technologies and know-how to develop innovative drug products for new chemical entities, aging compounds near the end of their life cycle, and difficult-to-formulate generics for highly regulated pharmaceutical markets.